Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17607552 | 0.96 | — | — | |
| SCHEMBL5985717 | 0.87 | — | — | |
| SCHEMBL5984834 | 0.77 | — | — | |
| SCHEMBL598898 | 0.76 | ALDH1A1 (0.50) | ALDH1A1TSHRHSD17B10 | |
| SCHEMBL7618 | 0.71 | — | — | |
| SCHEMBL1193514 | 0.71 | — | — | |
| SCHEMBL19226305 | 0.71 | ALDH1A1 (0.44) | ALDH1A1TSHRHSD17B10 | |
| SCHEMBL10474909 | 0.71 | — | — | |
| SCHEMBL82506 | 0.66 | — | — | |
| SCHEMBL81105 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117986215-A | 2-Phenyl-4-acyl benzofurans, preparation and application thereof | 中国医学科学院药物研究所 | 2024-05-07 | — | — | CN | claimed |
| CN-117986215-A | 2-Phenyl-4-acyl benzofurans, preparation and application thereof | 中国医学科学院药物研究所 | 2024-05-07 | — | — | CN | disclosed |
| CN-116693479-A | BysspinA derivative, preparation method and pharmaceutical application thereof | 中国医学科学院药物研究所 | 2023-09-05 | — | — | CN | disclosed |
| US-11345680-B2 | Method for producing bispyrrolidine compounds | BASF SE (DE) | 2022-05-31 | — | — | US | disclosed |
| US-20200392115-A1 | METHOD FOR PRODUCING BISPYRROLIDINE COMPOUNDS | BASF SE (DE) | 2020-12-17 | — | — | US | disclosed |
| EP-3713915-A1 | METHOD FOR PRODUCING BISPYRROLIDINE COMPOUNDS | BASF SE (DE) | 2020-09-30 | — | — | EP | disclosed |
| EP-3194371-B1 | ANTIMICROBIAL IMIDAZOLIUM COMPOUNDS | AGENCY SCIENCE TECH & RES (SG) | 2020-09-02 | — | — | EP | disclosed |
| CN-107108518-B | Antibacterial imidazolium compounds | 新加坡科技研究局 | 2020-08-11 | — | — | CN | disclosed |
| CN-111372916-A | Process for producing bispyrrolidine compounds | 巴斯夫欧洲公司 | 2020-07-03 | — | — | CN | disclosed |
| US-10570097-B2 | Antimicrobial imidazolium compounds | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2020-02-25 | — | — | US | disclosed |
| WO-2019101568-A1 | METHOD FOR PRODUCING BISPYRROLIDINE COMPOUNDS | BASF SE (DE) | 2019-05-31 | — | — | WO | disclosed |
| CN-105969543-B | Flue dust cleaning agent after fire | 江苏筑磊电子科技有限公司 | 2019-04-05 | — | — | CN | disclosed |
| US-20190016684-A1 | ANTIMICROBIAL IMIDAZOLIUM COMPOUNDS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2019-01-17 | — | — | US | disclosed |
| US-10160728-B2 | Antimicrobial imidazolium compounds | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2018-12-25 | — | — | US | disclosed |
| US-20170291877-A1 | ANTIMICROBIAL IMIDAZOLIUM COMPOUNDS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2017-10-12 | — | — | US | disclosed |
| CN-107108518-A | Antibacterial imidazolium compounds | 新加坡科技研究局 | 2017-08-29 | — | — | CN | disclosed |
| EP-3194371-A1 | ANTIMICROBIAL IMIDAZOLIUM COMPOUNDS | Agency for Science, Technology and Research (SG) | 2017-07-26 | — | — | EP | disclosed |
| CN-105969543-A | Smoke dust cleaning agent after fire hazards | 江苏筑磊电子科技有限公司 | 2016-09-28 | — | — | CN | disclosed |
| WO-2016043660-A1 | ANTIMICROBIAL IMIDAZOLIUM COMPOUNDS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2016-03-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10570097-B2 | Antimicrobial imidazolium compounds | CCNI, MACF1, ECI1 | ALDH1A1 3371/4885TSHR 3989/4885HSD17B10 2205/4885 |
| US-20200392115-A1 | METHOD FOR PRODUCING BISPYRROLIDINE COMPOUNDS | BBOX1, DHPS, BCKDK | ALDH1A1 397/4885TSHR 4272/4885HSD17B10 271/4885 |
| US-11345680-B2 | Method for producing bispyrrolidine compounds | BCKDK, BBOX1, DHPS | ALDH1A1 671/4885TSHR 4288/4885HSD17B10 337/4885 |
| US-10160728-B2 | Antimicrobial imidazolium compounds | CCNI, MACF1, ECI1 | ALDH1A1 3371/4885TSHR 3989/4885HSD17B10 2205/4885 |
| US-20170291877-A1 | ANTIMICROBIAL IMIDAZOLIUM COMPOUNDS | CCNI, MACF1, ECI1 | ALDH1A1 3371/4885TSHR 3989/4885HSD17B10 2205/4885 |
| US-20190016684-A1 | ANTIMICROBIAL IMIDAZOLIUM COMPOUNDS | CCNI, MACF1, ECI1 | ALDH1A1 3371/4885TSHR 3989/4885HSD17B10 2205/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.